TAHO PHARMACEUTICALS
Taihe Biotech Pharmaceutical Co., Ltd. (Taihe) is a biotechnology new drug development company that specializes in the development of a niche market with its own technology platform for its existing pharmaceutical products (Specialty Pharma) . Taihe adheres to the spirit of sincerity, credit and responsibility, carries out product development, and strictly abides by the latest international regulations to carry out all research and development work. It is expected that the product inspection mat... erials established will meet the requirements of advanced countries, in order to facilitate future entry into the international market and authorization. The international large-scale factory carried out follow-up development and obtained the drug certificate of the target drug in the shortest time. It is hoped that Gengyitai will be synthesized as a โ TDS New Drug Development Company โ and establish a Taiwan drug development industry value chain and success stories.
TAHO PHARMACEUTICALS
Social Links:
Industry:
Biotechnology Pharmaceutical
Founded:
2010-01-01
Status:
Active
Contact:
886 2 2659 8515
Email Addresses:
[email protected]
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Euro Apple Mobile Web Clips Icon Google Maps LetsEncrypt Mobile Non Scaleable Content Nginx
Similar Organizations
Magpie Pharmaceuticals
Magpie Pharmaceuticals is a biotechnology company.
Mimetogen Pharmaceuticals
Mimetogen Pharmaceuticals is a clinical-stage ophthalmology drug development company.
TWi Pharmaceuticals Holding Inc
TWi Pharmaceuticals, Inc. (TWi) is a technology-based special pharmaceutical company.
Current Advisors List
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2024-10-02 | Mithradote Bio | Taho Pharmaceuticals investment in Seed Round - Mithradote Bio | 1000 K USD |
More informations about "Taho Pharmaceuticals"
What We Do - ๆณฐๅ็ๆ่ฅๅ่กไปฝๆ้ๅ ฌๅธ
Driving Medical InnovationBridging The Gap In Current TreatmentsRaising Patient OutcomesTAHO is a commercial-stage specialty pharma pioneering in oral, transdermal drug delivery systems.Collaborating with our partners across โฆSee details»
INVESTOR OVERVIEW - ๆณฐๅ็ๆ่ฅๅ่กไปฝๆ้ๅ ฌๅธ
A Pioneer in Drug DeliveryTAHOis the first company from Taiwan to obtain Japan PMDA approval for a self-developed new dosage form drug, Ondasensetron ODF.WE STRIVE TO BE A โฆSee details»
Taho Pharmaceuticals - Crunchbase Investor Profile
Taihe Biotech Pharmaceutical Co., Ltd. (Taihe) is a biotechnology new drug development company that specializes in the development of a niche market with its own technology platform for its existing pharmaceutical products (Specialty โฆSee details»
TAHO Pharmaceuticals Ltd. - BIO International Convention | BIO
Jun 6, 2023 The Biotechnology Innovation Organization is the world's largest biotech trade association. Learn about BIO, register for events and explore member services. ... TAHO โฆSee details»
TAHO Pharmaceuticals Ltd. - Drug pipelines, Patents, Clinical trials ...
Explore TAHO Pharmaceuticals Ltd. with its drug pipeline, therapeutic area, technology platform, 1 clinical trial, Disease Domain:Nervous System Diseases, Technology ...See details»
Taho Pharmaceuticals - PitchBook
Taho Pharmaceuticals Ltd is a Taiwan based company focused on identifying and developing new products that offer therapeutic options to patient populations that may be under served. It โฆSee details»
Taho Pharmaceuticals Ltd - Company Profile and News
Company profile page for Taho Pharmaceuticals Ltd including stock price, company news, executives, board members, and contact informationSee details»
6467 - TAHO Pharmaceuticals Ltd. - ir-reports.com
Code: 6467, Market: Public CompanyTAHO Pharmaceuticals Ltd. is a Taiwan-based biopharmaceutical company. The Company engages in the research of drug delivery systems โฆSee details»
TAHO Pharmaceuticals Ltd. (Taiwan, China) - EMIS
Sep 9, 2022 TAHO Pharmaceuticals Ltd. is mainly engaged in medicine development and drug delivery system research. The company was founded in 2010 and is headquartered in Taipei, โฆSee details»
TAHO Pharmaceuticals - Craft
TAHO Pharmaceuticals (ๆณฐๅ็ๆ่ฅๅ) is a specialty pharma company focused on the debilitating side effects of cancer treatment and central nervous (CNS) system conditions. Its transdermal โฆSee details»
TAHO Pharmaceuticals Ltd. Company Profile - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for TAHO Pharmaceuticals Ltd. of Taipei City, Taipei. Get the latest business insights from Dun & โฆSee details»
Taiho Pharmaceutical - Wikipedia
Taiho Pharmaceutical Co., Ltd. (ๅคง้ตฌ่ฌๅๅทฅๆฅญ, Taihล Yakuhin Kลgyล) is a Japanese pharmaceutical company, and a subsidiary of Otsuka Holdings, which focuses on developing โฆSee details»
Leadership - ๆณฐๅ็ๆ่ฅๅ่กไปฝๆ้ๅ ฌๅธ
Chairman and CEOHoward Lee, PhDWith over25 years of healthcare investment and management experience. Mr. Lee has served as our Chairman and CEO and as a member of โฆSee details»
Taho Pharma - Company Profile - Tracxn
Dec 17, 2024 Taho Pharma is a speciality pharma company developing novel CNS and oncology drugs through their proprietary drug delivery platform. The company's transdermal โฆSee details»
Taho Pharma - Products, Competitors, Financials, Employees ...
Taho Pharma is a biotechnology company focused on the development of new drugs in the pharmaceutical industry. The company specializes in the development of innovative drug โฆSee details»
TAH-8801 - Drug Targets, Indications, Patents - Synapse - Patsnap
Nov 30, 2024 Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.See details»
TAH-6601 - Drug Targets, Indications, Patents - Synapse - Patsnap
TAH-6601, Initially developed by TAHO Pharmaceuticals Ltd., Now, its global highest R&D status is Preclinical, Therapeutic Areas: Nervous System Diseases, Active Indication: Epilepsy, โฆSee details»
History - ๆณฐๅ็ๆ่ฅๅ่กไปฝๆ้ๅ ฌๅธ
2021 Completion of Phase 1 Study of TAH3311 Anticoagulant Oral Film in Canada Patent Allowed US: TAH6601; China: TAH4411; Taiwan: TAH3301 2020 Patent Allowed China โฆSee details»
WHO calls for transformative action towards a greener future in ...
18 hours ago The World Health Organization (WHO), through its Department of Regulation and Prequalification, has issued a call for action to drive sustainability in the pharmaceutical sector. โฆSee details»
TAH-7702 - Drug Targets, Indications, Patents - Synapse - Patsnap
TAH-7702, Initially developed by TAHO Pharmaceuticals Ltd., Now, its global highest R&D status is Pending, Therapeutic Areas: Other Diseases. ... Originator Organization. TAHO โฆSee details»